XML 25 R3.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Income Statement [Abstract]      
Research and development expenses, net $ 7,618 $ 6,837 $ 5,491
General and administrative expenses 3,445 3,164 3,571
Operating loss 11,063 10,001 9,062
Financial income, net 473 236 244
Loss before income tax 10,590 9,765 8,818
Taxes on income (1) 6 8
Net loss 10,589 9,771 8,826
Comprehensive loss:      
Net loss 10,589 9,771 8,826
Change in fair value of cash flow hedge 13
Comprehensive loss $ 10,602 $ 9,771 $ 8,826
Loss per share:      
Net loss per ordinary share (in USD) basic and diluted $ 2.61 $ 6.72 $ 7.31
Weighted average number of ordinary shares outstanding - basic and diluted (in thousands) 4,058 1,455 1,208